Xenon Pharmaceuticals Inc (NASDAQ:XENE)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - XENE

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - XENE

  • Market Cap$379.000m
  • SymbolNASDAQ:XENE
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINCA98420N1050

Company Profile

Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders, including the rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901 and XEN496 for Epilepsy, XEN007 for Orphan neurological and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out through Canada.Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing a pipeline of differentiated therapeutics for orphan indications. Its products portfolio includes Glybera, TV-45070.

Latest XENE news

Currently there for this company. Visit our news hub for other news .